TriNetX to Present at ISPOR 2019 on the Power of Real-World Data to Impact Research Across a Wide Variety of Therapeutic Areas

CAMBRIDGE, Mass., May 6, 2019 /PRNewswire/ -- TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present eight posters at the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 annual meeting to be held May 18-22 in New Orleans, Louisiana. The presentations will illustrate the power of leveraging real-world data to generate real-world evidence across a wide variety of therapeutic areas.

"The real-world data available on the TriNetX network and the comprehensive analytics capability of the TriNetX platform enable researchers to produce real-world evidence that impacts the full gamut of healthcare," said Manfred Stapff, MD, PhD, Chief Medical Officer at TriNetX. "Good scientific practice requires validating results across two different data approaches. The administrative claims data and EMR clinical data in our network enables researchers to provide that validation. We look forward to discussing these emerging resources with our peers in the medical community at ISPOR."

Poster PDB7 - Diabetic Complications Associated with SGLT2 and DPP4 Inhibitors: A Real-World Approach

• Authors: Rutendo Kashambwa, Manfred Stapff
• Poster Session: SESSION II - PDB: DIABETES/ENDOCRINE/METABOLIC DISORDERS
• Monday, May 20, 2019, 3:30 PM – 7:00 PM
• Location: A7

Poster PDB8 - Using Real-World Data to Identify Subpopulations of Nonalcoholic Fatty Liver Disease (NAFLD) and Associations with Cardiovascular (CV) and Liver-Related Outcomes

• Authors: Laura Evans, Seth Kuranz, Richard Rast
• Poster Session: SESSION II - PDB: DIABETES/ENDOCRINE/METABOLIC DISORDERS
• Monday, May 20, 2019, 3:30 PM – 7:00 PM
• Location: A8

Poster PIH1 – Evaluation and Effectiveness of First-Line Treatments for Polycystic Ovary Syndrome (PCOS) Anovulatory Infertility: A Real-World Evidence Study

• Authors: Jennifer Stacey, Amy Cartaya
• Poster Session: SESSION II - PIH: INDIVIDUAL'S HEALTH
• Monday, May 20, 2019, 3:30 PM - 7:00 PM
• Location: E9

Poster PMS49 - Characteristics of Switching Biological Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis from Real-World Data

• Authors: Josh Hartman, Antonio Solano-Román
• Poster Session: SESSION II - PMS: MUSCULOSKELETAL DISORDERS
• Monday, May 20, 2019, 3:30 PM - 7:00 PM
• Location: K8

Poster PCV4 - Real-World Evidence of Recurrent Venous Thromboembolism in Elderly Patients: Differences by Pharmacologic Prophylaxis Treatment

• Author: Seth Kuranz
• Poster Session: SESSION III - PCV: CARDIOVASCULAR DISORDERS
• Tuesday, May 21, 2019, 10:30 AM – 2:00 PM
• Location: B29

Poster PIN60 - Lyme Disease First-Line Treatment and Progression in Florida and the Northeastern U.S.: A Comparison Using Real-World Data

• Authors: Stephan Palm, Becca Fink, Jennifer Stacey
• Poster Session: SESSION III - PIN: INFECTIOUS DISEASES
• Tuesday, May 21, 2019, 10:30 AM – 2:00 PM
• Location: H12

Poster PDG3 - Using Real-World Data to Examine the Association Between Fluoroquinolone Use and Aortic Aneurysm (AA)

• Authors: Seth Kuranz, Steve Kundrot
• Poster Session: SESSION IV - PDG: DRUGS & GENERICS
• Tuesday, May 21, 2019, 3:30 PM – 7:00 PM
• Location: A3

Poster PNS209 - Using Meta-Analysis to Evaluate Heterogeneity Across a Network of Health Data Providers

• Authors: Cindy Liu, Aongus O'Murchadha, Richard Rast
• Poster Session: SESSION V - PNS: NO SPECIFIC DISEASE
• Wednesday, May 22, 2019, 9:30 AM – 2:00 PM
• Location: I5

In addition, TriNetX will be conducting the following breakout workshop session:

W22 – Beyond Trial Replication: Using Real-World Data to Bridge the Efficacy-Effectiveness Gap in Healthcare

• Discussion Leaders: David Thompson, Syneos Health, Manfred Stapff, TriNetX, Joseph DiCesare, Allergan
• Wednesday, May 22, 2019, 2:00 PM – 3:00 PM

TriNetX will also be exhibiting in booth #601 in the ISPOR expo hall.

About TriNetX

TriNetX is the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence. TriNetX combines real time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions at the speed of thought. The TriNetX platform is HIPAA and GDPR compliant. For more information, visit TriNetX at http://www.trinetx.com or follow @TriNetX on Twitter.

Media Contact

TriNetX
Jennifer Haas
(857) 285-6052
[email protected]

SOURCE TriNetX

Related Links

http://www.trinetx.com